Next Article in Journal
An Approach to Traumatic Brain Injury-Related Hypopituitarism: Overcoming the Pediatric Challenges
Previous Article in Journal
Percutanous Electrochemotherapy (ECT) in Primary and Secondary Liver Malignancies: A Systematic Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Diagnostics
Volume 13
Issue 2
10.3390/diagnostics13020211
diagnostics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Diagnostic Considerations of Intermetatarsal Bursitis: A Systematic Review

by
Sif Binder Larsen
1,*,
Stinne Byrholdt Søgaard
1,2,
Michael Bachmann Nielsen
1 and
Søren Tobias Torp-Pedersen
1
1
Department of Diagnostic Radiology, Rigshospitalet, 2100 Copenhagen, Denmark
2
Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark
*
Author to whom correspondence should be addressed.
Diagnostics 2023, 13(2), 211; https://doi.org/10.3390/diagnostics13020211
Submission received: 7 December 2022 / Revised: 2 January 2023 / Accepted: 3 January 2023 / Published: 6 January 2023
(This article belongs to the Section Pathology and Molecular Diagnostics)
Browse Figure
Review Reports Versions Notes

Abstract

:
Intermetatarsal bursitis (IMB) is an inflammation of the intermetatarsal bursas. The condition causes forefoot pain with symptoms similar to those of Morton’s neuroma (MN). Some studies suggest that IMB is a contributing factor to the development of MN, while others describe the condition as a differential diagnosis. Among patients with rheumatic diseases, IMB is frequent, but the scope is yet to be understood. The aim of this paper was to investigate the diagnostic considerations of IMB and its role in metatarsalgia by a systematic review approach. We identified studies about IMB by searching the electronic databases Pubmed, Embase, Cochrane Library, and Web of Science in September 2022. Of 1362 titles, 28 met the inclusion criteria. They were subdivided according to topic: anatomical studies (n = 3), studies of patients with metatarsalgia (n = 10), and studies of patients with rheumatic diseases (n = 15). We conclude that IMB should be considered a cause of pain in patients with metatarsalgia and patients with rheumatic diseases. For patients presenting with spreading toes/V-sign, IMB should be a diagnostic consideration. Future diagnostic studies about MN should take care to apply a protocol that is able to differ IMB from MN, to achieve a better understanding of their respective role in forefoot pain.

1. Introduction

Intermetatarsal bursitis (IMB) is an inflammation of the intermetatarsal bursas located between the metatarsal heads, dorsal to the deep transverse metatarsal ligament [1]. The symptoms of IMB are very similar to those of Morton’s neuroma, with forefoot pain characterized by a sharp, stinging pain that worsens by walking and is often accompanied by numbness in the adjacent toes. The typical location of IMB is the 2nd and 3rd interspace [2].
IMB and Morton’s neuroma are described both as differential diagnoses, and IMB as a contributing factor to the development of Morton’s neuroma [3,4]. The intermetatarsal bursa is suggested to cause Morton’s neuroma in two ways; one suggests the intermetatarsal bursa as a part of the compression theory: swelling and compression of the bursa causes it to bulge and compress the neurovascular bundle [5], the other suggests that inflammation in the intermetatarsal bursa causes the fibrotic changes in the nerve [1]. Within the last decade, IMB has drawn more attention in the rheumatologic field, where an association between IMB and systemic inflammatory diseases such as rheumatoid arthritis and systemic lupus erythematosus is being investigated [6,7].
In the literature on forefoot pain and Morton’s neuroma, IMB occurs repeatedly. However, little consistency is found on the implications of IMB and additionally, inadequate literature exists on how to distinguish the two conditions. The orthopaedic surgeon or radiologist who deals with these diseases daily might know how to differ the two conditions, but limited studies on the subject make it hard to reproduce and standardize these observations. The role of IMB in metatarsalgia is not evident.
The aim of this paper is to investigate the diagnostic considerations of IMB and its role in metatarsalgia by conducting a systematic review to identify anatomical, histopathological, diagnostic, and treatment studies that include the intermetatarsal bursa or IMB. Furthermore, to discuss the potential implication for future diagnostic and treatment strategies.

2. Materials and Methods

This study was carried out according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) [8]. The review was not registred, but the protocol is available upon request to corresponding author. Our study was designed to answer the following ‘PICO’: Participants were patients with metatarsalgia or asymptomatic; Interventions included any intervention; Comparisons were not specified; and Outcome included results about IMB or the intermetatarsal bursa.
Search strategy: We conducted a literature search in the following databases: Pubmed, Embase, Cochrane Library, and Web of Science. The search was conducted by Sif Binder Larsen with the assistance of a hospital librarian, and last updated in September 2022. No limits or filters were applied in the searches, e.g., publication year or human studies.
Descriptions of IMB were primarily found in literature with a broader theme or different topic, e.g., Morton’s neuroma. Based on this, we performed a wide search to include all studies on IMB and Morton’s neuroma. The search strategy included three main designations of these pathologies with any possible variations of these: Morton neuroma, intermetatarsal neuroma, and IMB. Detailed search strategies are found in Supplementary Table S1.
In- and exclusion criteria: The following criteria were applied in the selection of studies: Inclusion: studies that mention intermetatarsal bursa/bursitis in the title and/or abstract, including studies that use any phrase that refers to the same anatomical structure or studies with a focus on differential diagnoses to Morton’s neuroma. Exclusion: studies including children (<18-years-old), veterinary studies, non-original studies, studies without full text accessible, or studies not available in an English translation.
Study selection and data extraction: Title and abstract screening and screening of full text for eligibility were done by two independent reviewers (Sif Binder Larsen and Stinne Byrholdt Søgaard) according to the predefined in- and exclusion criteria. Cases of disagreement were resolved by consensus in each step. In three cases of disagreement during the full-text screening, a third, senior assessor made the decision.
A total of 1362 articles were identified from the databases after duplicates were removed. A total of 88 proceeded to full-text review; of these 28 were included in the review. An outline of the review process and exclusion reasons are shown in Figure 1.
The following variables were extracted from the papers: First author, publishing year, type of study, design, the aim of study, study population, number of participants, female:male ratio, and mean age with (range) or ±standard deviation. The included articles were subdivided into three groups: anatomical studies (n = 3), studies on patients with metatarsalgia (n = 11), and studies on patients with autoimmune disorders, e.g., rheumatoid arthritis (n = 15). One study was placed in both the anatomical and the metatarsalgia group, because it was multipurpose. Results regarding IMB for each study are found in Supplementary Table S2.
Risk of bias: We assessed the risk of bias of the included studies using the Quality Assessment of Studies of Diagnostic Accuracy Studies (QUADAS-2) tool [9]. Due to the heterogeneity of the included studies, we chose the assessment tool that fits the majority of the studies. QUADAS-2 consists of four key domains: patient selection, index test, reference standard, and flow and timing. Each domain is assessed for risk of bias and the first three regard applicability. The risk of bias was carried out with assistance from the QUADAS-2 background document available from https://www.bristol.ac.uk/population-health-sciences/projects/quadas/quadas-2/, (accessed on 29 September 2022).

3. Results

3.1. Study Characteristics

3.1.1. Anatomical Studies

Three studies investigated the anatomic relations of the intermetatarsal bursas in cadaveric feet. An overview of the results is available in Table 1 (a). The presence of bursas in the second and third interspace and their distal extent to become interphalangeal was consistent in all three studies. The proximity to the neurovascular bundle in these interspaces is emphasized.

3.1.2. Patients with Metatarsalgia

Eleven studies investigated patients with metatarsalgia and/or asymptomatic participants. Overview of results in Table 1 (b). The studies are heterogeneous regarding both purpose and design. IMB is found to play a role in metatarsalgia and especially Morton’s neuroma in several ways: IMB was more frequent in postoperative Morton’s neuroma patients who had persistent pain [10], some studies reported a neuroma-bursa mass [11,12] while others differentiated between IMB and Morton’s neuroma as two independent causes of metatarsalgia [13,14].

3.1.3. Patients with Autoimmune Disorders

Fifteen studies investigated IMB in patients with autoimmune disorders (Table 1 (c)); mostly patients with rheumatoid arthritis, but also patients suspected to develop rheumatoid arthritis, osteoarthritis, or systemic lupus erythematosus. We noted a heterogeneity regarding the bursas investigated, as five of the studies pooled the results of both intermetatarsal bursitis and plantar bursitis.
Table
Table 1. Study overview.
Table 1. Study overview.
Author and YearType of Study and DesignAim of StudyStudy PopulationNo. of PatientsSex (F:M)Age (Years)
(a) Anatomical studies
Bossley et al. 1980 [1]Anatomical Investigate the role of the intermetatarsal bursa in MNCadaveric feetNANA19–70
Chauveaux et al. 1987 [5]AnatomicalDescribe the anatomic relations of the intermetatarsal bursaFresh (<72 h), cadaveric feet25NANA
Theumann et al. 2001 [15]AnatomicalCorrelate the MRI appearance of the intermetatarsal bursae with the anatomic sections and histopathologic analysisFresh, frozen cadaveric feet81:678 (75–86)
(b) Patients with metatarsalgia
Albano et al. 2021 [16]Diagnostic (US), retrospectiveDescribe US findings in pts treated with foot orthosesPts with metatarsalgia2015:562.6 (36–78)
Awerbuch et al. 1982 [17]Treatment, steroid injection and surgeryTreatment of Morton’s metatarsalgia by injected corticosteroid and surgeryPts diagnosed clinically with MN5044:648 (28–71)
Bencardino et al. 2000 [18]Diagnostic (MRI), retrospectiveDetermine the prevalence of clinically silent MNClinically symptomatic (S) and asymptomatic (A) pts with MN on MRI 44 (S: 25, A: 19)S: 21:4
A: 13:6		S: 49, A: 47
Bossley et al. 1980 [1]Diagnostic (D) and treatment (T) (anatomic part in section (a))Investigate the role of the intermetatarsal bursa in MND: Pts with forefoot pain and controls and T: Pts with clinical MN 11NANA
Cohen et al. 2016 [11]Diagnostic (US), prospectiveDetermine the sonographic appearance of MNPts diagnosed with MN having surgery85:555 (45–65)
Espinosa et al. 2010 [10]Diagnostic (MRI), prospectiveEvaluate the prevalence of postoperative MRI findings after MN resectionPost-neurectomy pts 5846:1245 (27–56)
Hassouna et al. 2007 [14]Treatment, steroid injectionThe clinical effect of US-guided injection in MNPts diagnosed clinically with MN3932:755.8 (26–83)
Iagnocco et al. 2001 [13]Diagnostic (US), prospectiveIdentify the changes in the forefoot of pts with metatarsalgiaPts with monolateral metatarsalgia11281:3158.9 (29–78)
Umans et al. 2014 [19]Diagnostic (MRI), retrospectiveIdentify the variety of second and third interspace lesions in relation to plantar plate tearsPts with metatarsalgia9661:3549
Volpe et al. 1998 [12]Histological, retrospectiveClassify the degree of nerve pathology and compare with the surgical outcomePts with MN in the third interspace32NANA
Zanetti et al. 1997 [20]Diagnostic (MRI), prospectiveDetermine the prevalence and size of asymptomatic MN and fluid in the intermetatarsal bursaAsymptomatic volunteers7035:3545.8 (30–79)
(c) Patients with autoimmune disorders
Albtoush et al. 2019 [21]Diagnostic (MRI and US), retrospectiveAssess the role of MRI in metatarsalgia and demonstrate the imaging features of IMB by MRI and USPts with an autoimmune disorder debuting with metatarsalgia due to IMB66:035.8 (20–59)
Bowen et al. 2010 [22]Diagnostic (US), prospectiveEvaluate the effect of anti-TNF therapy on the presence of forefoot pathology, pain, and disabilityPts with RA starting anti-TNF therapy3124:759.6 (37–76)
Bowen et al. 2010 [23]Diagnostic (US), prospectiveInvestigate the prevalence of FFB in US and explore the relationship between FFB and foot impairmentPts with RA12098:2260.7 ±12.1
Cherry et al. 2014 [24]Diagnostic (MRI), prospectiveTo develop a tool for evaluation of FFB at MRI in pts with RAPts with RA3023:761 ±4.1
Dakkak et al. 2020 [25]Diagnostic (MRI), prospectiveTo study the prevalence of IMB and SMB in RA pts compared to the other groupsPts with early (<2 years) RA, other arthritis (O), and healthy controls (C)RA: 157
O: 284
C: 193		109:48,
158:126,
136:57		59 ± 14, 56 ± 17, 50 ± 16
Dakkak et al. 2020 [26]Diagnostic (MRI), prospectiveInvestigate the relationship between physical joint examination and MRI-detected inflammation in MTP jointsPts with early (<2 years) inflammatory diseases441267:17457 ± 16
Dijk et al. 2021 [27]Diagnostic (MRI), prospectiveAssess the occurrence and prognostic value of IMBPts with clinically suspect arthralgia577433:14444 ± 13
Dijk et al. 2021 [28]Diagnostic (MRI), prospectiveInvestigate if IMB is a feature of early RAPts with early (<2 years) RA157109:4859 ± 14
Dijk et al. 2022 [29]Diagnostic (MRI), prospectiveInvestigate if IMB and tenosynovitis contribute to a positive MTP squeeze testPts with early (<2 years) RA and pts with clinically suspect arthralgia (S)RA: 192 and S: 693102:90, 507:18657 ± 15
NA
Endo et al. 2018 [30]Diagnostic (US), case studyEvaluate the use of power Doppler for examining FFB within US A RA pt with reduced foot mobility11:040
Hammer et al. 2019 [31] Diagnostic (US), retrospectiveInvestigate the prevalence of IMB and its association with subjective, clinical, and laboratory assessments in RA ptsPts with RA209169:4053 ± 13
Hooper et al. 2012 [6]Diagnostic (US), prospectiveDescribe the natural history of foot- related disability in pts with RA over three years. Pts with RA6051:962 (28–89)
Hooper et al. 2014 [32]Diagnostic (US), prospectiveInvestigate the prevalence and distribution of FFB in the tree groupsPts with RA, osteoarthritis, and healthy controlsRA: 56,
O: 50,
C: 50		NA41 (20–65)
66.3 (53–80)
62 (28–89)
Koski 1998 [33]Diagnostic (US), prospectiveTo detect bursitis in US and correlate findings with symptoms and clinical observationsPts with RA and healthy controlsRA: 25,
C: 30		15:10
18:12		48 (19–74)
45 (13–78)
Mukherjee et al. 2016 [7]Diagnostic (US), prospectiveDetermine the prevalence of US-detectable FFB and correlate this to patient-related disabilityPts with systemic lupus erythematosus2018:253.6 ± 12.8
IMB: intermetatarsal bursitis, MN: Morton’s neuroma, pt(s): patient(s), MRI: magnetic resonance imaging, US: ultrasound, FFB: forefoot bursas, RA: rheumatoid arthritis, C: healthy controls, SMB: Submetatarsal bursitis.

3.2. Synthesis of Results

3.2.1. Incidence

The incidence of IMB in patients with metatarsalgia is reported in two studies [13,16]. Iagnocco et al. 2000 report 21.4% (3/14) of examined patients and Albano report 81% (22/27) of examined feet. Hassouna et al. 2007 reported an incidence of IMB in a population with clinically diagnosed Morton’s neuroma and found that 31% (14/45) of patients had IMB [14]. The prevalence of IMB in patients with rheumatoid arthritis varied from 20.6% to 69%, with an average of 40.5% [31,33,34].

3.2.2. Diagnostic Imaging

Of the 28 articles included in this review, 2318 were diagnostic studies. The modalities used were ultrasound and MRI with 11 articles evaluating ultrasound and 10 evaluating MRI. One article from 1980 uses radiography and one uses both MRI and ultrasound [1,21]. The approach to diagnosing IMB varied between studies. All the rheumatic studies with MRI used contrast, while the MRI studies of patients with metatarsalgia were without. For ultrasound, especially the side of the foot scanned varied. Hammer et al. 2019 and Koski 1997 obtained the scans from the dorsal side of the foot while Bowen et al. 2010 scanned from the plantar side [22,31,33]. The rest scanned from both sides. Two of the ultrasound studies used power Doppler [30,31].
Zanetti et al., 1997, investigated asymptomatic intermetatarsal spaces with MRI [20]. They found that 67% of the participants had a fluid collection in at least one intermetatarsal bursa, concluding that fluid collections in the intermetatarsal bursa measuring ≤3 mm should be considered physiologic. Contrary to this, Theumann et al. 2001 note that no bursas were visible on MRI before the intrabursal contrast administration [15]. These contradictory findings might be explained by the fact that one study had living subjects and the other used cadaveric feet.

3.2.3. Clinical Diagnosis

Pain in the intermetatarsal space or metatarsalgia was the phrase used to describe the clinical symptoms of the patients, throughout the included studies. Detailed clinical examination information was limited, and no studies identified symptoms that could be specific to IMB. Albano et al. 2021 provided the most specific description. “To investigate the presence of bursitis, acupressure of metatarsal heads and intermetatarsal spaces was applied and the Mulder test was performed to assess the presence of an MN.” [16] (p. 964). Espinosa et al. 2010 and Hassouna et al. 2007 provided a more detailed description, but it focuses on diagnosing Morton’s neuroma. Dijk et al. 2022 found IMB to contribute to a positive squeeze test in patients with rheumatoid arthritis [29].

3.2.4. Opening Toes

Several articles mention that the spreading of the toes is associated with the presence of IMB in the interspace between the diverting toes. Awerbuch et al. 1982 reported that 45 out of 50 patients had swelling over the painful cleft [17]. Dakkak et al. 2020 reported that 21% of the swollen joints found at physical examination are explained by IMB alone in patients with rheumatoid arthritis [26]. This finding is in line with Koski et al. 1997 who suspected IMB in 5 out of 25 (20%) rheumatoid arthritis patients due to spreading of the toes [33]. Endo et al. 2018 and Hammer et al. 2019 also presented this symptom along with clinical pictures [30,31]. Several terms are used to address this symptom including spreading of the toes, opening toes, and swollen intermetatarsal spaces.

3.2.5. Treatment

Two treatment studies were identified in our search. Awerbuch et al. 1982 treated 50 patients [17]; 28 had complete relief with corticosteroid injections in the intermetatarsal bursa, while 22 had surgery, of which 20 patients had the interdigital nerve and the intermetatarsal bursa removed and two patients only had the interdigital nerve removed. The two patients where the bursa was not removed initially had recurring symptoms and were treated later with either corticosteroid injection or excision of the bursa, both with good results. This is in line with the findings of Espinosa et al. 2010 who showed that IMB is more frequent in symptomatic post-neurectomy patients [10]. Hassouna et al. 2007 treated 39 patients with corticosteroid injections of which 28% had complete relief, but the treatment effect is not evaluated according to ultrasound diagnosis of IMB or Morton’s neuroma, even though it is stated that 31% of the patients had IMB [14].

3.2.6. Autoimmune Disorders

Van Dijk et al. 2022 found IMB to behave and respond to treatment similar to known rheumatoid arthritis characteristics, supporting IMB as an inflammatory feature of rheumatoid arthritis [28]. Bowen et al. 2010 and Cherry et al. 2012 found an association between the presence of forefoot bursas (intermetatarsal and plantar bursas) at ultrasound evaluation and patient-reported disability, at one- and three-year follow-ups of the same cohort [6,23]. IMB is described as associated with the onset of rheumatoid arthritis [17,21,27] (Table 2).

3.3. Risk of Bias

Overall, the risk of bias in the included papers was assessed as low but with many unclear risks of bias due to non-reporting of some domains, see Supplementary Table S3. A recurring topic of concern was the inconsistency in the definition of forefoot bursas among the articles about autoimmune diseases. Some studies report the presence of both intermetatarsal and submetatarsal bursas under the common name forefoot bursas [7,22,32]. This limits the applicability of the results of these studies.
The predefined criteria for diagnosing IMB varied between the studies. There were differences in the location of the bursa in relation to the deep transverse metatarsal ligament [7] and four studies did not state which criteria they used to diagnose IMB [14,18,21,33]. The lack of predefined criteria causes a high risk of bias score under the index test domain. Regarding reference standards, we marked studies with unclear risk of bias, if they did not use a reference standard. Studies that used a pathological evaluation of surgical or dissection specimens received a low risk of bias evaluation, similar to the approach in systematic reviews about Morton’s neuroma [35,36].

4. Discussion

This study shows that IMB must be considered a cause of pain in patients with metatarsalgia, as well as patients with rheumatic diseases. In patients with a complaint of forefoot pain and the presence of spreading toes, IMB should be a diagnostic consideration. The identified studies address various aspects of the intermetatarsal bursa and IMB. There is agreement on the presence and location of the intermetatarsal bursas and the close relationship between the neurovascular bundle and the distal part of the intermetatarsal bursas.
The reported incidence of IMB range from 20.6% to 93.3% [23,31]. The incidences must be compared cautiously as very few of the studies are comparable due to a great variance in the study population and design. Some studies report the incidence based on the number of patients and others on the number of feet and some report incidences that include both intermetatarsal and submetatarsal bursitis. Additionally, different methods are applied in diagnostic studies to obtain ultrasound and MRI scans with the purpose of diagnosing IMB. Several of the included studies mention the clinical sign opening toes/swollen intermetatarsal spaces/V-sign in relation to IMB [17,30,31]. Widening of the intermetatarsal angle on radiographs, which we interpret as representing the same symptom, have also been linked to the presence of Morton’s neuroma, with a sensitivity between 30–73% [37,38]. No studies have investigated both conditions and the presence of opening toes, but the widening of the intermetatarsal space should raise clinical suspicion of both conditions.
The criteria for diagnosing IMB with ultrasound is described as “IMB is detected as a hypoechoic structure between the metatarsal heads” by Hammer et al. 2019 and by Albano et al. 2021 as “a hypo to anechoic fluid collection in the intermetatarsal space” [16,31]. Compared with the ultrasonic criteria for Morton’s neuroma: “The typical sonographic appearance is that of an ovoid, hypoechoic mass oriented parallel to the long axis of the metatarsals”, Redd et al. 1989 and by Oliver et Beggs 1998 “a round or oval hypoechoic mass was found between the metatarsal heads” [39,40]. The diagnostic criteria for IMB and Morton’s neuroma by ultrasound are very similar with the presence of a hypoechoic mass between the metatarsal heads. This might result in an overestimation of the condition one is looking for due to the similar ultrasonic presentation.
Diagnostic criteria for IMB on MRI include a contrast-enhanced lesion above the deep transverse ligament and between the metatarsal heads, either with or without rim enhancement [26]. Due to an inconsistent contrast enhancement pattern of Morton’s neuroma on MRI, Zanetti et al. 2005 recommended not to use contrast-enhanced images for MRI of Morton’s neuroma [41]. This causes a limitation in the exclusion of IMB or differentiation between an intermetatarsal bursa with fluid and IMB. The diagnostic criteria for Morton’s neuroma on MRI are a well-demarcated lesion at the level of the neurovascular bundle on the plantar side of the deep transverse metatarsal ligament, with a signal intensity that is low to intermediate on T1-weigthed images and hypointense to fatty tissue on T2-weigthed images [42,43]. Some studies report the presence of Morton’s neuroma, which occurs hyperintense on T2-weigthed images or extends dorsal and past the deep transverse metatarsal ligament [44,45]. This inconsistency in imaging results is noticeable—could these hyperintense/dorsal extending neuromas represent cases of intermetatarsal bursitis?
Cohen et al. 2016 suggested a common name to describe the conditions: neuroma-bursal complex, as their results suggested the two conditions to be coherent [11]. They observed a discrepancy between ultrasound and specimens’ measures similar to the results of Read et al. 1999 [11,46]. At histologic examination, both studies found that the nerve thickening was surrounded by scarred bursal tissue and they both described an intimate relationship between bursa and neuroma at theultrasound. We find this observation correlates with the Grade 1 Morton’s neuroma described by Volpe et al. 1998 [12]. Quinn et al. 2000 also questions the sonographic diagnosis of Morton’s neuroma due to the location of the intermetatarsal mass and they mentioned the intermetatarsal bursa as a cause [47]. A review article by Bianchi et al. 2014 described the target for steroid treatment for Morton’s neuroma to be the bursa, but also addresses IMB as an independent disease [48]. Overall this raises the questions: Is IMB a contributing factor in the development of Morton’s neuroma, and which condition is associated with the symptoms experienced by the patients? Diagnostic accuracy studies about Morton’s neuroma often use histological evaluation of surgical specimens as a reference standard. Some studies have questioned the value of the histological findings in specimens from Morton’s neuroma surgery due to the near 100% hit rate [49,50]. Pathologic studies of interdigital nerves from asymptomatic feet find macro- and microscopic alterations compatible with those of Morton’s neuroma—more commonly appearing with proceeding age, thereby concluding that Morton’s neuroma does not have a recognizable morphological substrate [51,52]. Four imaging studies have investigated the incidence of asymptomatic Morton’s neuromas [18,20,53,54]. With incidences of 25–53% (average 35.5%) alterations that fulfil the diagnostic criteria for Morton’s neuromas in asymptomatic patients are common and in line with the findings in the pathologic studies. This leads us to raise the question: Is IMB the cause of pain in the intermetatarsal spaces and Morton’s neuroma a painless, degenerative development of the interdigital nerve?
The mechanisms behind the development of IMB are not directly discussed in the included papers, except for Dijk et al. 2021 who found IMB to be linked with early rheumatoid arthritis. Looking at other types of bursitis (olecrani, iliopsoas, ect.), they are caused by mechanical forces such as trauma or overuse. In line with this, mechanical strain as a cause of IMB provides a reasonable explanation [55,56]. Rheumatoid arthritis is a risk factor for the development of bursitis—especially for early arthritis, as it is for IMB [57]. Our study has limitations that should be addressed. Descriptions of IMB is often a short paragraph in papers with another main focus, and some of these papers do not mention intermetatarsal bursa/bursitis in the title or abstract. This results in a selection bias, as these studies have not been included in our study.
The risk of bias in included studies adds to the risk of bias in our results. We found an inconsistency in the definition of forefoot bursas and in the stated predefined criteria to diagnose IMB. These inconsistencies might reflect the limited written knowledge of IMB and because of this, each paper reflects the authors’ own experience instead of a more uniform approach. Another limitation is that many of the included studies are more than 20 yearsold (10 out of 28). Due to technological advancement in the intermediate period, the conclusions from these studies might have been different in a current setting [36,58]. Among the included diagnostic studies, very few had a reference standard. The frequent use of conservative treatment for patients with metatarsalgia and medicine for patients with autoimmune disorders all limit the possibility for specimens for histopathological evaluation [16,22].
The lack of a reference standard combined with the notable difference in the diagnostic criteria for IMB, and advancement in the diagnostic technology might partly explain the dissemination of the results presented in this review article. This emphasizes a need to develop proper diagnostic criteria for IMB. IMB is yet to be definitively categorized as a differential diagnosis or a contributing factor in the development of Morton’s neuroma.

5. Conclusions

IMB must be considered a cause of pain in patients with metatarsalgia and patients with rheumatic diseases. In patients with forefoot pain and the presence of spreading toes/V-sign, IMB should be a diagnostic consideration.
Future diagnostic imaging studies would benefit from protocols that can differentiate IMB from other causes of forefoot pain—especially Morton’s neuroma, with the use of contrast in MRI studies and power Doppler in ultrasound studies. Furthermore, care should be taken in the differentiation between the physiologic fluid in the intermetatarsal bursa and IMB. Increased focus on IMB could aid a better understanding of its role in forefoot pain and has the potential to improve treatment strategies in the future.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/diagnostics13020211/s1, Table S1: Extended search history; Table S2: Results from each study regarding Intermetatarsal bursitis; Table S3: Overall risk of bias.

Author Contributions

Conceptualization, S.B.L., S.T.T.-P., and M.B.N.; methodology, S.B.L., S.T.T.-P., and M.B.N.; investigation, S.B.L. and S.B.S.; resources, M.B.N.; data curation, S.B.L.; writing—original draft preparation, S.B.L.; writing—review and editing, all authors; visualization, S.B.L.; supervision, S.T.T.-P. and M.B.N.; funding acquisition, S.B.L., S.T.T.-P., and M.B.N. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by The Danish Rheumatism Association, grant number R198-A6999.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Bossley, C.J.; Cairney, P.C. The intermetatarsophalangeal bursa—Its significance in Morton’s metatarsalgia. J. Bone Joint Surg Br. 1980, 62, 184–187. [Google Scholar] [CrossRef] [Green Version]
  2. Perini, L.; Del Borrello, M.; Cipriano, R.; Cavallo, A.; Volpe, A. Dynamic sonography of the forefoot in Morton’s syndrome: Correlation with magnetic resonance and surgery. Radiol. Med. 2006, 111, 897–905. [Google Scholar] [CrossRef]
  3. Jain, S.; Mannan, K. The diagnosis and management of Morton’s neuroma: A literature review. Foot Ankle Spec. 2013, 6, 307–317. [Google Scholar] [CrossRef]
  4. Ganguly, A.; Warner, J.; Aniq, H. Central Metatarsalgia and Walking on Pebbles: Beyond Morton Neuroma. AJR Am. J. Roentgenol. 2018, 210, 821–833. [Google Scholar] [CrossRef]
  5. Chauveaux, D.; Le Huec, J.C.; Midy, D. The supra-transverse intermetatarsocapital bursa: A description and its relation to painful syndromes of the forefoot. Surg. Radiol. Anat. 1987, 9, 13–18. [Google Scholar] [CrossRef]
  6. Hooper, L.; Bowen, C.J.; Gates, L.; Culliford, D.J.; Ball, C.; Edwards, C.J.; Arden, N.K. Prognostic indicators of foot-related disability in patients with rheumatoid arthritis: Results of a prospective three-year study. Arthritis Care Res. 2012, 64, 1116–1124. [Google Scholar] [CrossRef]
  7. Mukherjee, S.; Cherry, L.; Zarroug, J.; Culliford, D.; Bowen, C.; Arden, N.; Edwards, C. A pilot investigation of the prevalence of US-detectable forefoot joint pathology and reported foot-related disability in participants with systemic lupus erythematosus. J. Foot Ankle Res. 2016, 9, 27. [Google Scholar] [CrossRef] [Green Version]
  8. Liberati, A.; Altman, D.G.; Tetzlaff, J.; Mulrow, C.; Gøtzsche, P.C.; Ioannidis, J.P.; Clarke, M.; Devereaux, P.J.; Kleijnen, J.; Moher, D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J. Clin. Epidemiol. 2009, 62, e1–e34. [Google Scholar] [CrossRef] [Green Version]
  9. Whiting, P.F.; Rutjes, A.W.; Westwood, M.E.; Mallett, S.; Deeks, J.J.; Reitsma, J.B.; Leeflang, M.M.; Sterne, J.A.; Bossuyt, P.M. QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies. Ann. Intern. Med. 2011, 155, 529–536. [Google Scholar] [CrossRef]
  10. Espinosa, N.; Schmitt, J.W.; Saupe, N.; Maquieira, G.J.; Bode, B.; Vienne, P.; Zanetti, M. Morton neuroma: MR imaging after resection--postoperative MR and histologic findings in asymptomatic and symptomatic intermetatarsal spaces. Radiology 2010, 255, 850–856. [Google Scholar] [CrossRef]
  11. Cohen, S.L.; Miller, T.T.; Ellis, S.J.; Roberts, M.M.; DiCarlo, E.F. Sonography of Morton Neuromas: What Are We Really Looking At? J. Ultrasound. Med. 2016, 35, 2191–2195. [Google Scholar] [CrossRef] [PubMed]
  12. Volpe, A.; Tognon, S.; Fassina, A. Morton’s syndrome: Surgical strategies according to the digital nerve pathology. Foot Ankle Surg. 1998, 4, 129–137. [Google Scholar] [CrossRef]
  13. Iagnocco, A.; Coari, G.; Palombi, G.; Valesini, G. Sonography in the study of metatarsalgia. J. Rheumatol. 2001, 28, 1338–1340. [Google Scholar] [PubMed]
  14. Hassouna, H.; Singh, D.; Taylor, H.; Johnson, S. Ultrasound guided steroid injection in the treatment of interdigital neuralgia. Acta Orthop. Belg. 2007, 73, 224–229. [Google Scholar] [PubMed]
  15. Theumann, N.H.; Pfirrmann, C.W.; Chung, C.B.; Mohana-Borges, A.V.; Haghighi, P.; Trudell, D.J.; Resnick, D. Intermetatarsal spaces: Analysis with MR bursography, anatomic correlation, and histopathology in cadavers. Radiology 2001, 221, 478–484. [Google Scholar] [CrossRef] [PubMed]
  16. Albano, D.; Bonifacini, C.; Zannoni, S.; Bernareggi, S.; Messina, C.; Galia, M.; Sconfienza, L.M. Plantar forefoot pain: Ultrasound findings before and after treatment with custom-made foot orthoses. Radiol. Med. 2021, 126, 963–970. [Google Scholar] [CrossRef] [PubMed]
  17. Awerbuch, M.S.; Shephard, E.; Vernon-Roberts, B. Morton’s metatarsalgia due to intermetatarsophalangeal bursitis as an early manifestation of rheumatoid arthritis. Clin. Orthop. Relat. Res. 1982, 167, 214–221. [Google Scholar] [CrossRef]
  18. Bencardino, J.; Rosenberg, Z.S.; Beltran, J.; Liu, X.; Marty-Delfaut, E. Morton’s neuroma: Is it always symptomatic? AJR Am. J. Roentgenol. 2000, 175, 649–653. [Google Scholar] [CrossRef]
  19. Umans, H.; Srinivasan, R.; Elsinger, E.; Wilde, G.E. MRI of lesser metatarsophalangeal joint plantar plate tears and associated adjacent interspace lesions. Skelet. Radiol. 2014, 43, 1361–1368. [Google Scholar] [CrossRef]
  20. Zanetti, M.; Strehle, J.K.; Zollinger, H.; Hodler, J. Morton neuroma and fluid in the intermetatarsal bursae on MR images of 70 asymptomatic volunteers. Radiology 1997, 203, 516–520. [Google Scholar] [CrossRef]
  21. Albtoush, O.M.; Xenitidis, T.; Horger, M. Intermetatarsal bursitis as first disease manifestation in different rheumatological disorders and related MR-imaging findings. Rheumatol. Int. 2019, 39, 2129–2136. [Google Scholar] [CrossRef] [PubMed]
  22. Bowen, C.J.; Edwards, C.J.; Hooper, L.; Dewbury, K.; Sampson, M.; Sawyer, S.; Burridge, J.; Arden, N.K. Improvement in symptoms and signs in the forefoot of patients with rheumatoid arthritis treated with anti-TNF therapy. J. Foot Ankle Res. 2010, 3, 10. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Bowen, C.J.; Hooper, L.; Culliford, D.; Dewbury, K.; Sampson, M.; Burridge, J.; Edwards, C.J.; Arden, N.K. Assessment of the natural history of forefoot bursae using ultrasonography in patients with rheumatoid arthritis: A twelve-month investigation. Arthritis Care Res. 2010, 62, 1756–1762. [Google Scholar] [CrossRef]
  24. Cherry, L.; King, L.; Thomas, M.; Roemer, F.; Culliford, D.; Bowen, C.J.; Arden, N.K.; Edwards, C.J. The reliability of a novel magnetic resonance imaging-based tool for the evaluation of forefoot bursae in patients with rheumatoid arthritis: The FFB score. Rheumatology 2014, 53, 2014–2017. [Google Scholar] [CrossRef] [Green Version]
  25. Dakkak, Y.; Niemantsverdriet, E.; Van Der Helm-Van Mil, A.; Reijnierse, M. Increased frequency of inter- and submetatarsal bursitis and morton’s neuroma in rheumatoid arthritis: Results of a large case-controlled mri study of forefeet in patients with early arthritis and healthy controls. Ann. Rheum. Dis. 2020, 79 (Suppl. 1), 1237–1238. [Google Scholar] [CrossRef]
  26. Dakkak, Y.J.; Boer, A.C.; Boeters, D.M.; Niemantsverdriet, E.; Reijnierse, M.; Van Der Helm-Van Mil, A.H.M. The relation between physical joint examination and MRI-depicted inflammation of metatarsophalangeal joints in early arthritis. Arthritis Res. Ther. 2020, 22, 67. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. van Dijk, B.T.; Wouters, F.; van Mulligen, E.; Reijnierse, M.; van der Helm-van Mil, A.H.M. During development of rheumatoid arthritis, intermetatarsal bursitis may occur before clinical joint swelling: A large imaging study in patients with clinically suspect arthralgia. Rheumatology 2021, 61, 2805–2814. [Google Scholar] [CrossRef]
  28. van Dijk, B.T.; Dakkak, Y.J.; Matthijssen, X.M.E.; Niemantsverdriet, E.; Reijnierse, M.; van der Helm-van Mil, A.H.M. Intermetatarsal bursitis, a novel feature of juxta-articular inflammation in early rheumatoid arthritis that is related to clinical signs: Results of a longitudinal MRI-study. Arthritis. Care Res. 2022, 74, 1713–1722. [Google Scholar] [CrossRef]
  29. van Dijk, B.T.; Dakkak, Y.J.; Krijbolder, D.K.; van Zeben, D.; Tchetverikov, I.; Reijnierse, M.; van der Helm-van Mil, A.H.M. Which inflamed tissues explain a positive metatarsophalangeal squeeze test? A large imaging study to clarify a common diagnostic procedure. Rheumatology 2022, 61, 4107–4112. [Google Scholar] [CrossRef]
  30. Endo, Y.; Koga, T.; Eguchi, M.; Okamoto, M.; Tsuji, S.; Takatani, A.; Shimizu, T.; Sumiyoshi, R.; Igawa, T.; Kawashiri, S.; et al. Utility of power Doppler ultrasonography for detecting forefoot bursae in early rheumatoid arthritis A case report. Medicine 2018, 97, 4. [Google Scholar] [CrossRef]
  31. Hammer, H.; Kvien, T.; Terslev, L. Intermetatarsal Bursitis Is Prevalent in Patients with Established Rheumatoid Arthritis and Is Associated with Anti-CCP and RF. Arthritis Rheumatol. 2019, 71, 3. [Google Scholar]
  32. Hooper, L.; Bowen, C.J.; Gates, L.; Culliford, D.; Arden, N.K.; Edwards, C.J. Comparative distribution of ultrasound-detectable forefoot bursae in patients with osteoarthritis and rheumatoid arthritis. Arthritis Care Res. 2014, 66, 869–877. [Google Scholar] [CrossRef] [Green Version]
  33. Koski, J.M. Ultrasound detection of plantar bursitis of the forefoot in patients with early rheumatoid arthritis. J. Rheumatol. 1998, 25, 229–230. [Google Scholar]
  34. Dakkak, Y.J.; Niemantsverdriet, E.; van der Helm-van Mil, A.H.M.; Reijnierse, M. Increased frequency of intermetatarsal and submetatarsal bursitis in early rheumatoid arthritis: A large case-controlled MRI study. Arthritis Res. 2020, 22, 277. [Google Scholar] [CrossRef] [PubMed]
  35. Xu, Z.; Duan, X.; Yu, X.; Wang, H.; Dong, X.; Xiang, Z. The accuracy of ultrasonography and magnetic resonance imaging for the diagnosis of Morton’s neuroma: A systematic review. Clin Radiol. 2015, 70, 351–358. [Google Scholar] [CrossRef] [PubMed]
  36. Bignotti, B.; Signori, A.; Sormani, M.P.; Molfetta, L.; Martinoli, C.; Tagliafico, A. Ultrasound versus magnetic resonance imaging for Morton neuroma: Systematic review and meta-analysis. Eur. Radiol. 2015, 25, 2254–2262. [Google Scholar] [CrossRef]
  37. Zaleski, M.; Tondelli, T.; Hodel, S.; Rigling, D.; Wirth, S. The interphalangeal angle as a novel radiological measurement tool for Morton’s neuroma—A matched case-control study. J. Foot Ankle Res. 2021, 14, 62. [Google Scholar] [CrossRef]
  38. Galley, J.; Sutter, R.; Germann, C.; Pfirrmann, C.W.A. The Vulcan salute sign: A non-sensitive but specific sign for Morton’s neuroma on radiographs. Skelet. Radiol. 2022, 51, 581–586. [Google Scholar] [CrossRef]
  39. Oliver, T.B.; Beggs, I. Ultrasound in the assessment of metatarsalgia: A surgical and histological correlation. Clin Radiol. 1998, 53, 287–289. [Google Scholar] [CrossRef]
  40. Redd, R.A.; Peters, V.J.; Emery, S.F.; Branch, H.M.; Rifkin, M.D. Morton neuroma: Sonographic evaluation. Radiology 1989, 171, 415–417. [Google Scholar] [CrossRef]
  41. Zanetti, M.; Weishaupt, D. MR imaging of the forefoot: Morton neuroma and differential diagnoses. Semin. Musculoskelet. Radiol. 2005, 9, 175–186. [Google Scholar] [CrossRef] [PubMed]
  42. Thomas, J.L.; Blitch, E.L.; Chaney, D.M.; Dinucci, K.A.; Eickmeier, K.; Rubin, L.G.; Stapp, M.D.; Vanore, J.V.; Clinical Practice Guideline, F. Diagnosis and Treatment of Forefoot Disorders. Section 3. Morton’s Intermetatarsal Neuroma. J. Foot Ankle Surg. 2009, 48, 251–256. [Google Scholar] [CrossRef] [PubMed]
  43. Claassen, L.; Bock, K.; Ettinger, M.; Waizy, H.; Stukenborg-Colsman, C.; Plaass, C. Role of MRI in detection of Morton’s neuroma. Foot Ankle Int. 2014, 35, 1002–1005. [Google Scholar] [CrossRef] [PubMed]
  44. Mandai, K.; Tada, M.; Yamada, Y.; Aono, M.; Hidaka, N. A case of splaying toes caused by Morton’s neuroma indicates early rheumatoid arthritis. Mod. Rheumatol. Case Rep. 2018, 2, 1–4. [Google Scholar] [CrossRef]
  45. Ho, S.C.; Lui, T.H.; Tam, K.F. Radiological approach to forefoot pain. J. Orthop. Trauma Rehabil. 2015, 19, 7–14. [Google Scholar]
  46. Read, J.W.; Noakes, J.B.; Kerr, D.; Crichton, K.J.; Slater, H.K.; Bonar, F. Morton’s metatarsalgia: Sonographic findings and correlated histopathology. Foot Ankle Int. 1999, 20, 153–161. [Google Scholar] [CrossRef] [PubMed]
  47. Quinn, T.J.; Jacobson, J.A.; Craig, J.G.; Van Holsbeeck, M.T. Sonography of Morton’s neuromas. Am. J. Roentgenol. 2000, 174, 1723–1728. [Google Scholar] [CrossRef] [PubMed]
  48. Bianchi, S. Practical US of the forefoot. J. Ultrasound 2014, 17, 151–164. [Google Scholar] [CrossRef] [Green Version]
  49. Mallina, R.K.; Al-Dadah, K.; Patel, K.; Ramesh, P. Is Histopathological Analysis of Interdigital Morton’s Neuroma Necessary? Foot Ankle Spec. 2017, 10, 520–523. [Google Scholar] [CrossRef]
  50. Raouf, T.; Rogero, R.; McDonald, E.; Fuchs, D.; Shakked, R.J.; Winters, B.S.; Daniel, J.N.; Pedowitz, D.I.; Raikin, S.M. Value of Preoperative Imaging and Intraoperative Histopathology in Morton’s Neuroma. Foot Ankle Int. 2019, 40, 1032–1036. [Google Scholar] [CrossRef]
  51. Bourke, G.; Owen, J.; Machet, D. Histological comparison of the third interdigital nerve in patients with Morton’s metatarsalgia and control patients. Aust. New Zealand J. Surg. 1994, 64, 421–424. [Google Scholar] [CrossRef] [PubMed]
  52. Morscher, E.; Ulrich, J.; Dick, W. Morton’s intermetatarsal neuroma: Morphology and histological substrate. Foot Ankle Int. 2000, 21, 558–562. [Google Scholar] [CrossRef]
  53. Owens, R.; Gougoulias, N.; Guthrie, H.; Sakellariou, A. Morton’s neuroma: Clinical testing and imaging in 76 feet, compared to a control group. Foot Ankle Surg. 2011, 17, 197–200. [Google Scholar] [CrossRef] [PubMed]
  54. Symeonidis, P.D.; Iselin, L.D.; Simmons, N.; Fowler, S.; Dracopoulos, G.; Stavrou, P. Prevalence of interdigital nerve enlargements in an asymptomatic population. Foot Ankle Int. 2012, 33, 543–547. [Google Scholar] [CrossRef] [PubMed]
  55. Johnston, C.A.; Wiley, J.P.; Lindsay, D.M.; Wiseman, D.A. Iliopsoas bursitis and tendinitis. A review. Sport. Med. 1998, 25, 271–283. [Google Scholar] [CrossRef]
  56. Aaron, D.L.; Patel, A.; Kayiaros, S.; Calfee, R. Four common types of bursitis: Diagnosis and management. J. Am. Acad Orthop. Surg. 2011, 19, 359–367. [Google Scholar] [CrossRef] [Green Version]
  57. Grassi, W.; De Angelis, R.; Lamanna, G.; Cervini, C. The clinical features of rheumatoid arthritis. Eur. J. Radiol. 1998, 27 (Suppl. 1), S18–S24. [Google Scholar] [CrossRef]
  58. Sconfienza, L.M.; Albano, D.; Allen, G.; Bazzocchi, A.; Bignotti, B.; Chianca, V.; Facal de Castro, F.; Drakonaki, E.E.; Gallardo, E.; Gielen, J.; et al. Clinical indications for musculoskeletal ultrasound updated in 2017 by European Society of Musculoskeletal Radiology (ESSR) consensus. Eur. Radiol. 2018, 28, 5338–5351. [Google Scholar] [CrossRef]
Diagnostics 13 00211 g001 550
Figure 1. Review process overview.
Figure 1. Review process overview.
Diagnostics 13 00211 g001
Table
Table 2. Summary of results.
Table 2. Summary of results.
Incidence of IMB21.4–81% of patients with metatarsalgia
31% of patients clinically diagnosed with MN
20.6–69% of patients with RA, average 40.5%
Diagnostic imaging23 diagnostic studies
11 ultrasound
10 MRI
-
Studies of rheumatic patients used contrast, n = 6
-
Studies of patients with metatarsalgia did not use contrast, n = 4
1 both MRI and ultrasound
1 radiography
Clinical diagnosisNot systematically investigated
Opening toesPresence of swelling or spreading toes was reported in 20-90% of cases
TreatmentIMB is associated with persistent symptoms after surgical treatment of MN
Autoimmune disordersIMB is frequent in the early stages of RA, responds in line with other RA symptoms to treatment and is associated with patient-reported disability
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Larsen, S.B.; Søgaard, S.B.; Nielsen, M.B.; Torp-Pedersen, S.T. Diagnostic Considerations of Intermetatarsal Bursitis: A Systematic Review. Diagnostics 2023, 13, 211. https://doi.org/10.3390/diagnostics13020211

AMA Style

Larsen SB, Søgaard SB, Nielsen MB, Torp-Pedersen ST. Diagnostic Considerations of Intermetatarsal Bursitis: A Systematic Review. Diagnostics. 2023; 13(2):211. https://doi.org/10.3390/diagnostics13020211

Chicago/Turabian Style

Larsen, Sif Binder, Stinne Byrholdt Søgaard, Michael Bachmann Nielsen, and Søren Tobias Torp-Pedersen. 2023. "Diagnostic Considerations of Intermetatarsal Bursitis: A Systematic Review" Diagnostics 13, no. 2: 211. https://doi.org/10.3390/diagnostics13020211

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop